10 ways in which current macro upheavals in China will impact global life sciences industry by insights10 - HTML preview

/ Home / Free Previews / 10 ways in which current macro upheavals in China will impact global life sciences industry

PLEASE NOTE: This is an HTML preview only and some elements such as links or page numbers may be incorrect.
Download the book in PDF, ePub, Kindle for a complete version.

A Market Research Report on

10 Ways in which

Current Macro

Upheavals in China

will Impact Global

Life Sciences

Industry

What would this Report Cover?

10 Macro Upheavals in China Impacting Global Healthcare

Unabated European

The highlights and

Strengthening global

Integrating countries

Focusing on

pharma investment in

lowlights faced by Chinese

health through

through commercial

regulatory reforms

China

vaccine developers

R&D

partnerships

Increasing commitments

Accelerating Industrial

Consolidation within the

Export and Sales of Medical

Promoting the

to health assistance and

Transformation and

service provider

Devices and Consumables

Internationalization of the

cooperation

Talent Development

space

across Nations Globally

Pharmaceutical Industry

Macro Upheavals Impacting Global Healthcare (1/5) The Highlights and

Unabated European

Lowlights Faced by

Pharma Investment in

Chinese Vaccine

China

Developers

▪ Big Pharma players are investing in China-specific projects and

▪ An intriguing microcosm of the status of development of the entire growing their footprint across the mainland as China represents an business can be seen in the highs and lows encountered by ever-increasing share of their global profits Chinese vaccine developers in their quest to deploy a COVID-19

vaccine

▪ In order to more effectively and comprehensively connect with Chinese medication developers, Boehringer Ingelheim (BI) built a

▪ While Chinese companies were among the first in the world to new hub in Shanghai to consolidate its R&D, and business introduce vaccine candidates into the clinic, validating the development operations in China

advancements made by the country's overall biopharmaceutical industry and significantly raising the stature of Chinese scientific

▪ Additionally, Novo Nordisk unveiled ambitious intentions to research abroad, it was ultimately a Big Pharma-backed vaccine combine their Chinese and international businesses with an from Pfizer and German biopharma player BioNTech that first emphasis on clinical development

crossed the finish line

▪ Novo Nordisk’s "China Essentials" program seeks to simultaneously

▪ Chinese-developed COVID-19 vaccines received approval for submit clinical trial applications for new drugs in China and routine or emergency use in China and several other nations, other countries for the first time, with a goal of 90 percent by 2025

including the UAE, Egypt, and Brazil, but not by the US or the EU, which were regarded as the world's two most stringent regulatory bodies

Macro Upheavals Impacting Global Healthcare (2/5) Integrating Countries

Strengthening Global

through Commercial

Health through R&D

Partnerships

▪ China’s 14th Five-Year Plan calls for an average annual increase

▪ Chinese and British agencies convene as part of a bilateral Global in R&D spending across the industry of more than 10%; in Health Dialogue that determines areas of shared interest for addition to the requirements for the innovative development of the potential future cooperation

pharmaceutical industry in the fundamental principles, these requirements are also reflected in terms of development goals

▪ Chinese government is assisting the Africa Centres for Disease Control and Prevention (CDC) and has also inked MOUs with

▪ By 2025, the share of newly sold innovative items in the increase the WHO and numerous bilateral partners to address some in operating revenue for the entire industry will further rise healthcare constraints

▪ The National Natural Science Foundation of China (NSFC) and the

▪ Private health sector businesses, organizations engaged in health China Grand Challenges project were established to promote research, and other entities are being engaged by China and scientific and technical innovation that may address important foreign partners

issues facing emerging nations

▪ This might entail setting up a platform for cooperation in global

▪ The initiative has supported research on AIDS vaccine health and technical professionals and should develop a mutual development, child and maternal mortality, tuberculosis (TB) understanding as a foundation for more productive collaboration treatments, vaccines, and more at prestigious universities, research centers, and hospitals in China

Macro Upheavals Impacting Global Healthcare (3/5) Increasing Commitments

Focusing on Regulatory

to Health Assistance and

Reforms

Cooperation

▪ China is collaborating with international partners to remove

▪ China is promoting global health by covering the agreements for obstacles that prevent more high-quality and reasonably priced working with African nations, like FOCAC for health cooperation Chinese healthcare products from entering the global market, which could have a larger impact on world health

▪ Under FOCAC, a forum for China-Africa health development has been established, and agreements have been made to offer health

▪ To provide technical support and support reforms that bring aid to African nations

Chinese regulations and standards in clinical trials, drug approval, and manufacturing into line with international norms, WHO and the

▪ As part of efforts to boost international cooperation, the National Medical Products Administration which is China's main Chinese government has signed MOUs with several multilateral regulatory agency for drugs and medical devices have come organizations, most notably the WHO for global health together

▪ China is actively developing better health policies, demonstrating

▪ Chinese businesses can more easily pursue concurrent domestic its commitment to playing a greater role in global health, and certification and WHO prequalification of their products beginning to demonstrate the thematic goals, kinds of cooperation, and levels of engagement that the government envisions 5

Macro Upheavals Impacting Global Healthcare (4/5) Accelerating Industrial

Consolidation within the

Transformation and

Service Provider

Talent Development

Space

▪ The development of the pharmaceutical industry in China depends

▪ The biopharma boom in China has also energized the CRO and on encouraging technical collaboration in the pharmaceutical CDMO space, with demand greatly outstripping supply across many area between business, academia, research facilities, and fundamental services, through acquisitions, Chinese pharmaceutical hospitals, as well as on maximizing the potential of those working in businesses are expanding their market share and entering the that sector globally

global pharmaceutical outsourcing sector

▪ In order to improve collaboration with scientific research

▪ In order to increase its CDMO capability and market reach in institutions and jointly create a national strategic scientific force in Europe, WuXi AppTec made an agreement with Bristol Myers the field of biomedicine, the 14th Five-Year Plan emphasizes its Squibb to purchase the latter's production plant in Couvet, support for innovative pharmaceutical firms Switzerland in 2021

▪ Additionally, the strategy calls for funding the establishment of

▪ To improve its CMC capabilities in the UK and China, Pharmaron independent pharmaceutical R&D organizations, assisting in the purchased a commercial API production plant from Recipharm in creation of premier clinical research facilities, and enhancing the the beginning of 2022

capabilities of clinical research design and research services

▪ These transactions represent a grown Chinese CRO and CMO

market, which grew at a CAGR of 30.8% from 2016 to 2021, much faster than the global average of 9.5%.

Macro Upheavals Impacting Global Healthcare (5/5) Export and Sales of

Promoting the

Medical Devices and

Internationalization of the

Consumables across

Pharmaceutical Industry

Nations Globally

▪ In numerous healthcare sub-sectors, China is the second-largest

▪ In terms of going worldwide, China is promoting to support healthcare market in the world, offers the potential to global businesses in synchronizing the registration of novel exporters

medications in China and abroad as well as conducting international multi-center clinical research for developed nations

▪ The most active and vitally essential segment of the Chinese healthcare market for international enterprises continues to be

▪ The globalization of China's pharmaceutical business includes the medical equipment

process of internationalization that also involves the exit of native pharmaceutical firms and the admission of foreign

▪ Medical equipment with advanced technology is typically imported, pharmaceutical firms

while low to mid-range market segments are dominated by native products

▪ This is carried out by actively enticing multinational corporations to establish R&D centers and innovative drug

▪ China's medical device industry is anticipated to grow at a CAGR of manufacturing bases in China, as well as by using cooperative 6.2% from 2020 to 2025, bringing about USD38.4 billion by 2025

development and technology licensing to realize the entry of foreign pharmaceutical companies, in order to drive the development of the

▪ The diagnostics, imaging, and consumables subsectors of the domestic pharmaceutical industry companies Chinese medical device industry accounted for about 50% of the market's value

Who should buy this report?

HealthTech

MedTech

Pharmaceutical

Digital Health

Healthcare

Companies

Players

Entities

Providers

Topics of Upcoming Reports

10 Ways in which Technology is Driving Better Efficiency in Clinical Trials

Digital Therapeutics Regulatory Process, Updates and Trends Cost of this report:

Will the Expiry of Humira Market Exclusivity and Entry of its Biosimilars Move the Needle in BioPharma Market?

$2,500

From the Fringes to the Forefront: mRNA is here to Transform Global Health

Annual Subscription:

Melting the Iron Triangle: 10 Healthcare Players aiming Beyond Health Equality to Conquer Health Equity $125,000 $60,000

Robotics: Embarking a New Era in Surgical Innovations (Includes a total of 50 reports) Metaverse: Paving the way for Health 4.0

Healthcare Future Outlook 2023

Patient Engagement- a New Standpoint on Care that is Patient-Centered

www.insights10.com

E-Rx, the Digital Version of Prescription Improvising the Chances of Better Patient Outcomes

Methodology & Scope

Research Methodology

▪

Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions

▪

We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources

▪

For forecasting, the following parameters are considered:

❑

Market drivers and restraints along with their current and expected impacts

❑

Technological scenario and expected developments

❑

End use industry trends and dynamics

❑

Trends in the consumer behavior

❑

Regulatory scenario and expected developments

❑

Current capacity and expected capacity additions up to 2030

▪

We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate

▪

We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions

▪

All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)

▪

Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn) 11

A Sample Report on Singapore Physiotherapy Market Analysis I Confidential

Analysis Methodology

Our Analysis Methodology involves three critical stages: Market Data Analysis

Interpretation &

Data Collection

& Statistical Model

Presentation

Analysis &

Market Trends

Interpretation

Secondary

Research

Market Sizing &

Insights

Analysis

Primary

Research

Data Triangulation &

Presentation &

Validation

Reporting

A Sample Report on Singapore Physiotherapy Market Analysis I Confidential

Data Triangulation & Data Validation Top Down Approach

Final

Final Market size break up to

Market

rest of segmentation

Size

Validation from

Arriving at market size

Primary Interview

of each segment

Summarization of revenue

generated from companies

Validation from

to arrive at total market size

Primary Interview

Revenue generated by products & Final

services offered by companies

Summary

Bottom Up Approach

A Sample Report on Singapore Physiotherapy Market Analysis I Confidential

Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets

Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables

Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities

Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 14

A Sample Report on Singapore Physiotherapy Market Analysis I Confidential

Time Frame

Report Attribute

Details

Quantitative Units

Revenue in USD Million/Billion (Mn/Bn) Base Year for

2021

Estimation

Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Report Coverage

Company Profiles, Competitive Landscape, Regulatory Landscape, Future Opportunities Report Customization (5 working days) with purchase. We will provide you with data that is Customized Report

currently not a part of our scope as a part of 2022-Forecast

customization

2030

Period

Pricing and purchase

Avail customized purchase options to meet options

your exact research needs

What kind of Data is Presented

in this Report?

This report presents data, which is: Reliable

Expert-verified

Real

Comprehensive

Easy to read

The report is prepared

The data is prepared by

Allowing you to

Covers everything you

You do not have to be a

using a proven

a team of highly qualified

confidently make

would need to know

market expert to

methodology and

& experienced research

smarter business

about the market

understand what really is

insightful research

analysts & vetted by our

and strategic

including market size,

happening on the market

local associates

decisions

competitive analysis &

and how it works

much more

www.insights10.com

About

Lifesciences Market

Research Reports you

can trust

A large database of over 30,000 syndicated market research reports in pharmaceuticals and healthcare sector at global, regional as well as country level. We also provide customized research reports tailor made to suit your needs

www.insights10.com

Get Insights to take

informed Business

Decisions

Insights10 is a healthcare focused market research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for businesses

www.insights10.com

Market Research Reports

across various domains of healthcare Pharmaceuticals

Digital

Medical

Healthcare

OTC &

Clinical

(Diseases & Drugs) Health

Devices

Services

Nutraceuticals

Trials

Market Research Reports

Full-Time Engagement

Customized Reports

Conference Coverage

Our

Primary Research

Services

Competitive Intelligence

Strategic Research Projects

Regulatory Compliance

Database Services

Report Subscription Services

Our Research Process

Identification of

Market

Collection of

Collaboration

Verification &

Data

Dynamics

Data

of Data

Analysis

www.insights10.com

Statistical Databases

Company Websites/Annual Reports

Data

Sources

Trade Publications

We have access to multiple highly

Online Databases

reliable free and subscription data

sources. We have many years of

experience to understand which

Published Research Reports

sources are more dependable for what and which to prefer for the reliable and Whitepapers

latest information.

Press Releases of Key Market Players

www.insights10.com

Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.

Our team has

conducted market

research across 62+

global markets in

America, Europe,

Middle East, Africa and

Asia Pacific regions

Research Projects Done

Project Leadership Team

Dr. Purav Gandhi

Mukesh Nayak

Ritu Baliya

Atharva Bahad

Founder & CEO

Head - Marketing

Engagement Manager

Consultant

Purav is a physician and an

Mukesh is an engineering graduate

Ritu has over 6 years of experience in Atharva is a B.Tech (Biotechnology) and entrepreneur with 12+ years of

with an MBA in Marketing. He is a

strategy building, market assessments, MBA in Hospital and Health Management experience in Healthcare & Life

seasoned healthcare market

market sizing, and RWE for global MNC

with 2 years of experience working in Sciences industry spanning across

research & marketing professional healthcare & biopharma clients across consulting and project management in strategy, market access, health

with a progressive experience of over diff. markets (America, Europe, Africa, healthcare and Non-Government

informatics and RWE, digital health, 20 years in Life Sciences, Pharma

APAC and Middle East). Her areas of

organizations. Conducted

analytics and data science. Purav

and Medical Device sectors. With an

expertise include: Indentifying emerging comprehensive research and market

studied medicine from Gujarat

in-depth understanding of primary

trends in life sciences industry,

sizing exercise to understand the

University and also completed his MBA research, he has conducted

Competitor landscape assessment,

business potential for modern digital from IIM-Kozhikode. Purav started his hundreds of interviews of various

Disease opportunity assessments etc.

trends. Conducted comprehensive

career with Deloitte working on strategy stakeholders in pharma & healthcare She is a pro in secondary and primary secondary research for the subjects

consulting engagements and also co-

& completed several research

research with a deep domain expertise including the UK Mobility Aids market, founded ConvergeHealth by Deloitte.

projects across life sciences industry.

in healthcare sector.

Brazil’s Ophthalmology market, etc.